One Wealth Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$737K Buy
15,365
+7,986
+108% +$343K 0.21% 70
2026
Q1
$304K Buy
7,379
+3,078
+72% +$146K 0.13% 83
2025
Q4
$219K Buy
+4,301
New +$220K 0.09% 123
2025
Q1
Sell
-5,090
Closed -$438K 112
2024
Q4
$438K Buy
+5,090
New +$550K 0.22% 58

Other funds holding NVO

One Wealth Capital Management's NVO Position: Q2 2026 in Review

One Wealth Capital Management increased its Novo Nordisk (NVO) stake by 108% in Q2 2026, buying an estimated $343K and bringing the position to 15,365 shares worth $737K. The position accounts for 0.21% of the portfolio, ranked #70.

One Wealth Capital Management first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • One Wealth Capital Management held 15,365 shares of Novo Nordisk worth $737K as of Q2 2026.
  • One Wealth Capital Management bought 7,986 Novo Nordisk shares in Q2 2026, an estimated $343K.
  • Novo Nordisk made up 0.21% of One Wealth Capital Management's portfolio in Q2 2026, its #70 holding.
  • One Wealth Capital Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on One Wealth Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.